If we have any methods to widen CI in parallel design with high variance drug? [RSABE / ABEL]

posted by ElMaestro  – Denmark, 2021-02-02 11:12 (508 d 03:34 ago) – Posting: # 22200
Views: 1,034

Hi libaiyi,

» (...) So my quesion is if we have any method to widen the CI like RSABE in cross-over study?

I don't think there is any authority generally willing to widen the acceptance range in parallel trials involving humans (they'd perhaps do it if you were studying pMDI's in vitro etc).

Pass or fail!

Complete thread:

UA Flag
 Admin contact
22,166 posts in 4,645 threads, 1,572 registered users;
online 3 (0 registered, 3 guests [including 2 identified bots]).
Forum time: Saturday 15:47 CEST (Europe/Vienna)

Absolute certainty is a privilege of uneducated minds  and fanatics.
It is, for scientific folk, an unattainable ideal.    Cassius J. Keyser

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz